The Long-HER Study: Clinical and Molecular Analysis of Patients with HER2+ Advanced Breast Cancer Who Become Long-Term Survivors with Trastuzumab-Based Therapy

• Angelo Gámez-Pozo,

  Affiliation Instituto de Genética Médica y Molecular (INGEMM) – IdiPAZ, Hospital La Paz, Madrid, Spain

  ⨯
• Ramón M. Pérez Carrión,

  Affiliation Medical Oncology Department, Hospital Quirón, Pozuelo de Alarcón, Madrid, Spain

  ⨯
• Luis Manso,

  Affiliation Medical Oncology Department, Hospital 12 de Octubre, Madrid, Spain

  ⨯
• Carmen Crespo,

  Affiliation Medical Oncology Department, Hospital Ramón y Cajal, Madrid, Spain

  ⨯
• Cesar Mendiola,

  Affiliation Medical Oncology Department, Hospital 12 de Octubre, Madrid, Spain

  ⨯
• Rocío López-Vacas,

  Affiliation Instituto de Genética Médica y Molecular (INGEMM) – IdiPAZ, Hospital La Paz, Madrid, Spain

  ⨯
• Julia Berges-Soria,

  Affiliation Instituto de Genética Médica y Molecular (INGEMM) – IdiPAZ, Hospital La Paz, Madrid, Spain

  ⨯
• Isabel Álvarez López,

  Affiliation Medical Oncology Department, Hospital de Donostia, San Sebastián, Pais Vasco, Spain

  ⨯
• Mireia Margeli,

  Affiliation Medical Oncology Department, Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain

  ⨯
• Juan L. Bayo Calero,

  Affiliation Medical Oncology Department, Hospital Juan Ramón Jiménez, Huelva, Spain

  ⨯
• Xavier González Farre,

  Affiliation Medical Oncology Department, Hospital Clinic de Barcelona, Barcelona, Spain

  ⨯
• Ana Santaballa,

  Affiliation Medical Oncology Department, Hospital La Fe, Valencia, Spain

  ⨯
• Eva M. Ciruelos,

  Affiliation Medical Oncology Department, Hospital 12 de Octubre, Madrid, Spain

  ⨯
• Ruth Afonso,

  Affiliation Medical Oncology Department, Hospital Nuestra Señora de la Candelaria, Santa Cruz de Tenerife, Spain

  ⨯
• Juan Lao,

  Affiliation Medical Oncology Department, Hospital Miguel Servet, Zaragoza, Spain

  ⨯
• Gustavo Catalán,

  Affiliation Medical Oncology Department, Hospital Son Llàtzer, Palma de Mallorca, Spain

  ⨯
• José V. Álvarez Gallego,

  Affiliation Medical Oncology Department, Complejo Hospitalario de Zamora, Zamora, Spain

  ⨯
• José Miramón López,

  Affiliation Medical Oncology Department, Hospital Serranía de Ronda, Ronda, Málaga, Spain

  ⨯
• Francisco J. Salvador Bofill,

  Affiliation Medical Oncology Department, Hospital Virgen de Valme, Sevilla, Spain

  ⨯
• Manuel Ruiz Borrego,

  Affiliation Medical Oncology Department, Hospital Virgen del Rocío, Sevilla, Spain

  ⨯
• Enrique Espinosa,

  Affiliation Medical Oncology Department, Hospital La Paz, Madrid, Spain

  ⨯
• Juan A. Fresno Vara,

  Affiliation Instituto de Genética Médica y Molecular (INGEMM) – IdiPAZ, Hospital La Paz, Madrid, Spain

  ⨯
•  [ ... ],
• Pilar Zamora

  * E-mail: zamorapilar@gmail.com

  Affiliation Medical Oncology Department, Hospital La Paz, Madrid, Spain

  ⨯
• [ view all ]
• [ view less ]